Advanced search×

Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART.

Int J Hematol 91(1):140-5 (2010) PMID 20033800

The availability of highly active anti-retroviral therapy (HAART) has greatly improved the outcome of human immunodeficiency virus type-1 (HIV-1) infection and disease. We report here on a case of an HIV-1-seropositive patient with acute myelogenous leukemia who underwent a successful allogeneic unrelated bone marrow transplantation following HAART. A 40-year-old Japanese HIV-seropositive man underwent allogeneic unrelated bone marrow transplantation using a myeloablative pretransplant-conditioning regimen. Neutrophil engraftment occurred on day +18, and donor chimerism was achieved on day +27. During pre- and post- transplantation, the HAART was not interrupted. Over 1 year after transplantation, the patient is alive and in continuous complete remission with undetectable levels of HIV-1 RNA. HAART can lead to a successful hematopoietic stem cell transplantation without severe opportunistic infections.

DOI: 10.1007/s12185-009-0467-2
Version: za2963e q8zac q8zbb q8zc4 q8zd2 q8ze8 q8zfc q8zg1

Similar articles you may find interesting…

  1. To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century.

    Bone Marrow Transplant (2013) PMID 23645167

    AML treatment presents significant challenges in the elderly, who more often have poor risk cytogenetic and molecular markers, comorbidities and compromised performance status. Although population-based studies indicate that treated patients' survival is better than those who are not...
  2. Better primary stability with porous titanium particles than with bone particles in cemented impaction grafting: An in vitro study in synthe...

    J Biomed Mater Res B Appl Biomater (2013) PMID 23650084

    Cemented acetabular revision reconstructions with porous TiP show better initial stability despite less cement penetration than bone particle reconstructions. Realistic preclinical in vivo testing should explore the hypothesis that porous TiP offer a safe alternative to the current gold standard of...
  3. Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?

    J Clin Pathol (2013) PMID 23661716

    We tend to classify lung cancer by smoking status for screening purpose. With the discoveries of many actionable driver mutations such as activating EGFR mutations and ALK rearrangement in adenocarcinoma of the lung we have switched to classifying non-small cell lung cancer into different individual...